Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 5/20 | 1.00 |
| ▸ | ARG2 | P78540 | 6/20 | 0.72 |
| ▸ | ARG1 | P05089 | 4/20 | 0.72 |
| ▸ | GSR | P00390 | 2/20 | 0.52 |
| ▸ | GRM8 | O00222 | 1/20 | 0.52 |
| ▸ | GRM6 | O15303 | 1/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30726883 | 1.00 | GGT1 (1.00) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL6702428 | 0.86 | ARG2 (0.88) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL6702426 | 0.86 | ARG2 (0.88) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL215523 | 0.84 | ARG2 (1.00) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL215522 | 0.84 | ARG2 (1.00) | GGT1ARG2ARG1GSRGRM8 | |
| Hydrochloric Acid SCHEMBL29572780 | 0.82 | ARG2 (1.00) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL6704320 | 0.81 | ARG2 (0.78) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL6704317 | 0.81 | ARG2 (0.78) | GGT1ARG2ARG1GSRGRM8 | |
| SCHEMBL28273160 | 0.80 | GGT1 (0.66) | GGT1ARG2ARG1GRIK1SLC1A3 | |
| SCHEMBL28271686 | 0.79 | GGT1 (0.63) | GGT1ARG2ARG1GRIK1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361885-B1 | USE OF GAMMA-GT INHIBITORS FOR THE TREATMENT OF CHRONIC DEGENERATIVE DISEASES | GTX PHARMACEUTICALS GMBH (DE) | 2008-04-16 | — | — | EP | claimed |
| US-20040115284-A1 | Use of gamma-GT inhibitors for the treatment of degenerative diseases | GTX PHARMACEUTICALS GMBH (DE) | 2004-06-17 | — | — | US | claimed |
| EP-1361885-A1 | USE OF $G(G)-GT INHIBITORS FOR THE TREATMENT OF DEGENERATIVE DISEASES | GTX Pharmaceuticals GmbH (DE) | 2003-11-19 | — | — | EP | claimed |
| WO-2002066047-A1 | USE OF $G(G)-GT INHIBITORS FOR THE TREATMENT OF DEGENERATIVE DISEASES | GTX PHARMACEUTICALS GMBH (DE) | 2002-08-29 | — | — | WO | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| WO-2009043114-A1 | ARSENOXIDE COMPOUND AND METHOD OF USE | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2009-04-09 | — | — | WO | disclosed |
| EP-1361885-B1 | USE OF GAMMA-GT INHIBITORS FOR THE TREATMENT OF CHRONIC DEGENERATIVE DISEASES | GTX PHARMACEUTICALS GMBH (DE) | 2008-04-16 | — | — | EP | disclosed |
| US-20040115284-A1 | Use of gamma-GT inhibitors for the treatment of degenerative diseases | GTX PHARMACEUTICALS GMBH (DE) | 2004-06-17 | — | — | US | disclosed |
| EP-1361885-A1 | USE OF $G(G)-GT INHIBITORS FOR THE TREATMENT OF DEGENERATIVE DISEASES | GTX Pharmaceuticals GmbH (DE) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002066047-A1 | USE OF $G(G)-GT INHIBITORS FOR THE TREATMENT OF DEGENERATIVE DISEASES | GTX PHARMACEUTICALS GMBH (DE) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002028869-A1 | GAMMA-GLUTAMYL TRANSPEPTIDASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH (US) | 2002-04-11 | — | — | WO | disclosed |